Descuento:
-5%Antes:
Despues:
107,69 €1. Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications
2. Governmental and Academic Efforts to Advance the Field of Pharmacogenomics
3. Incorporating Pharmacogenomics in Drug Development: Industry and Regulatory Perspectives
4. Translating Pharmacogenomic Research to Therapeutic Potentials
5. Pharmacogenomics in Cancer Therapeutics
6. Pharmacogenomics in Cardiovascular Diseases
7. Pharmacogenomics in Psychiatry Disorders
8. Role of Pharmacogenomics in HIV Infection
9. Role of Pharmacogenomics in Diabetes
10. A Look to the Future: Pharmacogenomics, Pharmacoepigenomics, and System Biology - Data Technologies of Today and Tomorrow
11. The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging and Pharmacovigilance
12. Pharmacogenomics in Latin American Population
13. Reactive, Point-of-Care, Pre-emptive and Direct-to-Consumer Pharmacogenomic Testing
14. Economic Evaluation of Pharmacogenomic Testing: Lessons from Psychiatric Pharmacogenomics
15. Pharmacogenomics Education and Clinical Practice Guidelines
• Provides viewpoints that focus on the scientific and translational challenges and opportunities associated with advancing the field of pharmacogenomics
• Highlights progress in both the research and clinical areas of pharmacogenomics, as well as relevant implementation experience, challenges, and perspectives on direct-to-consumer genetic testing
• Includes, where applicable, discussion points, review questions, and cases for self-assessment purposes and to facilitate in-depth discussion
Authors
• Yui-Wing Francis Lam, Professor of Pharmacology, Minnie Stevens Piper Professor (2018), James O’Burke Endowed Centennial, Fellow in Pharmacy, University of Texas Health Science Center, San Antonio, TX, USA
• Scott R. Stuart, MD, Associate Professor, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Division Head, Pharmacogenomics, Sema4, Stamford, CT, USA
-5%
-5%
-5%
-5%
-5%
-5%
